FDA Drug recall D-1133-2022
Morbillinum, Potency:7C, 8C, 9C, 10C 12C, 13C, 15C, 20C, 21C, 30C, 200 C,Liquid Pellets, OTC, Washington Homeopathic Products, 260 JR Hawve…
- FDA Drug
- Class II
- terminated
- Published 2022-06-22
On 2022-06-22 the FDA classified a Class II recall of Morbillinum, Potency:7C, 8C, 9C, 10C 12C, 13C, 15C, 20C, 21C, 30C, 200 C,Liquid Pellets, OTC, Washington Homeopathic Products, 260 JR Hawve… by Washington Homeopathic Products, citing cGMP deviations.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1133-2022 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2022-05-13 |
| Published | 2022-06-22 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Washington Homeopathic Products |
| Distribution | US |
Product
Morbillinum, Potency:7C, 8C, 9C, 10C 12C, 13C, 15C, 20C, 21C, 30C, 200 C,Liquid Pellets, OTC, Washington Homeopathic Products, 260 JR Hawvermale Way, Berkeley Springs, WV 25411
Reason
cGMP deviations
Identifiers
| code_info | Lot# 20307, 20309 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1133-2022%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.